ROSENBROCK; Holger

Patent Applications and Registrations

Patent applications and USPTO patent grants for ROSENBROCK; Holger.The latest application filed is for "treatment of cognitive impairment associated with schizophrenia".

Company Profile

3.22.21

ROSENBROCK; Holger - Mittelbiberach DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Treatment Of Cognitive Impairment Associated With Schizophrenia App 20220047562 - PODHORNA; Jana ; et al.	2022-02-17
Medical Use Of Compound Iii App 20210130362 - SAND; Michael Steven ; et al.	2021-05-06
Medical use of compound III Grant 10,919,898 - Sand , et al. February 16, 2	2021-02-16
Anti-trkb Antibodies App 20200399378 - HERRMANN; Rolf ; et al.	2020-12-24
Anti-TrkB antibodies Grant 10,793,634 - Herrmann , et al. October 6, 2	2020-10-06
Anti-trkb Antibodies App 20180355046 - Herrmann; Rolf ; et al.	2018-12-13
Medical Use of Compound III App 20180237445 - SAND; Michael Steven ; et al.	2018-08-23
6-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disorders Grant 9,328,120 - Heine , et al. May 3, 2	2016-05-03
Derivatives of 4-(piperazinylcarbonyl)thiane-1, 1-dione which inhibit GlyT1 Grant 9,233,953 - Hoenke , et al. January 12, 2	2016-01-12
Compounds for the treatment of CNS disorders Grant 9,102,679 - Giovannini , et al. August 11, 2	2015-08-11
1-heterocyclyl-1,5-dihydro-pyrazolo[3,4-D] pyrimidin-4-one derivatives and their use as PDE9A modulators Grant 9,096,603 - Giovannini , et al. August 4, 2	2015-08-04
Compounds for the treatment of CNS disorders Grant 9,079,905 - Fuchs , et al. July 14, 2	2015-07-14
Phenyl-3-aza-bicyclo[3.1.0]hex-3-yl-methanones and the use thereof as medicament Grant 9,012,489 - Giovannini , et al. April 21, 2	2015-04-21
Piperazine derivatives and the use thereof as medicament App 20150105397 - HOENKE; Christoph ; et al.	2015-04-16
6-cycloalkyl-pyrazolopyrimidinones For The Treatment Of Cns Disorders App 20150025088 - HEINE; Niklas ; et al.	2015-01-22
6-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disorders Grant 8,912,201 - Heine , et al. December 16, 2	2014-12-16
Compounds For The Treatment Of Cns Disorders App 20140350025 - GIOVANNINI; Riccardo ; et al.	2014-11-27
1-heterocyclyl-1,5-dihydro-pyrazolo[3,4-d] Pyrimidin-4-one Derivatives And Their Use As Pde9a Modulators App 20140073641 - GIOVANNINI; Riccardo ; et al.	2014-03-13
1, 5-dihydro-pyrazolo (3, 4-D) pyrimidin-4-one derivatives and their use as PDE9A mudulators for the treatment of CNS disorders Grant 8,648,085 - Eickmeier , et al. February 11, 2	2014-02-11
1-heterocyclyl-1,5-dihydro-pyrazolo[3,4-D] pyrimidin-4-one derivates and their use as PDE9A modulators Grant 8,623,879 - Giovannini , et al. January 7, 2	2014-01-07
Compounds for the treatment of CNS disorders Grant 8,623,901 - Giovannini , et al. January 7, 2	2014-01-07
Phenyl-3-aza-bicyclo[3.1.0]hex-3-yl-methanones and the use thereof as medicament App 20130197011 - GIOVANNINI; Riccardo ; et al.	2013-08-01
6-Cycloalkyl-pyrazolopyrimidinones for the Treatment of CNS Disorders App 20120202829 - Heine; Niklas ; et al.	2012-08-09
Compounds For The Treatment Of Cns Disorders App 20120115863 - Fuchs; Klaus ; et al.	2012-05-10
New Compounds For The Treatment Of Cns Disorder App 20110212960 - HEINE; Niklas ; et al.	2011-09-01
1-heterocyclyl-1,5-dihydro-pyrazolo[3,4-d] Pyrimidin-4-one Derivates And Their Use As Pde9a Modulators App 20110184000 - Giovannini; Riccardo ; et al.	2011-07-28
New Compounds For The Treatment Of Cns Disorders App 20110082137 - GIOVANNINI; Riccardo ; et al.	2011-04-07
1, 5-dihydro-pyrazolo (3, 4-d) Pyrimidin-4-one Derivatives And Their Use As Pde9a Mudulators For The Treatment Of Cns Disorders App 20110015193 - Eickmeier; Christian ; et al.	2011-01-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.